Cite Filings / TSHA / 0001415889-25-015487

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Taysha Gene Therapies, Inc. Filed 2025-06-03 Acc 0001415889-25-015487

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-06-04 4 Director acquired 56,623 shares (grant or award)
2025-06-04 4 Director acquired 56,623 shares (grant or award)
2025-06-04 4 Director acquired 56,623 shares (grant or award)
2025-06-04 4 Director acquired 56,623 shares (grant or award)
2025-06-03 SCHEDULE 13D/A Beneficial Ownership Report
2025-06-03 4 10% owner bought 750,000 shares at $2.75 ($2,062,500)
2025-06-03 8-K Bylaws or fiscal year change · Shareholder vote results

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…